Skip to main content

Table 1 Background characteristics of the study participants

From: Associations between pulmonary congestion on chest ultrasound and survival in hemodialysis patients

Characteristic Quantity
Gender (M/F) 29/32
Age (year) 75.2 ± 10.7
Duration of HD (year) 6.2 ± 8.4
Primary cause of ESKD, n (%)
 Chronic glomerulonephritis 10 (16.4)
 Diabetic nephropathy 28 (45.9)
 Nephrosclerosis 13 (21.3)
 Unknown and others 10 (16.4)
Hypertension, n (%) 53 (86.9)
Diabetes mellitus, n (%) 28 (45.9)
Dyslipidemia, n (%) 11 (18.0)
Atrial fibrillation, n (%) 8 (13.1)
Body weight (kg) 52.3 ± 10.8
Systolic blood pressure (mmHg) 145 ± 26
Diastolic blood pressure (mmHg) 74 ± 15
Heart rate (beat/min) 75 ± 13
Albumin (g/dL) 3.1 ± 0.6
Urea nitrogen (mg/dL) 50.0 ± 17.9
Creatinine (mg/dL) 7.3 ± 2.6
Sodium (mEq/L) 137 ± 4
C-reactive protein (mg/dL) 1.06 ± 2.19
Hemoglobin (g/dL) 10.4 ± 1.3
NT-proBNP (pg/mL) 13,851 (4764–34,279)
LVDd (mm) 45.7 ± 7.0
LVDs (mm) 30.8 ± 7.8
LVEF (%) 60.1 ± 13.4
Maximum WT (mm) 11.5 ± 1.7
UFR (kg/h) 0.51 ± 0.24
UFR/BW (1/h) 0.99 ± 0.42
ΔB-lines/pre B-lines 0.59 ± 0.22
  1. Mean ± SD median (interquartile range), HD hemodialysis, ESKD end-stage kidney disease, LVDd left ventricular end-diastolic dimension, LVDs left ventricular end-systolic dimension, LVEF left ventricular ejection fraction, WT wall thickness, UFR ultrafiltration rate, BW body weight